AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma

Published:2015-03-12 Issue:11 Volume:21 Page:2601-2612
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Brand Toni M.,Iida Mari,Stein Andrew P.,Corrigan Kelsey L.,Braverman Cara M.,Coan John P.,Pearson Hannah E.,Bahrar Harsh,Fowler Tyler L.,Bednarz Bryan P.,Saha Sandeep,Yang David,Gill Parkash S.,Lingen Mark W.,Saloura Vassiliki,Villaflor Victoria M.,Salgia Ravi,Kimple Randall J.,Wheeler Deric L.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AXL inhibition prevents RPA2/CHK1-mediated homologous recombination to increase PARP inhibitor sensitivity in hepatocellular carcinoma;Heliyon;2024-09

2. Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications;British Journal of Cancer;2024-06-17

3. Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2;Scientific Reports;2024-04-26

4. MICA+ Tumor Cell Upregulated Macrophage-Secreted MMP9 via PROS1-AXL Axis to Induce Tumor Immune Escape in Advanced Hepatocellular Carcinoma (HCC);Cancers;2024-01-08

5. Discovery of novel and potent dual-targeting AXL/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular docking, molecular dynamics simulation studies, and biological evaluation;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-12-22